In vitro activity of non-bactericidal concentrations of polymyxin B in combination with other antimicrobials against OXA-23-producing carbapenem-resistant Acinetobacter baumannii

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages 502-504

  Netto, Bárbara ^a   Vieira, Bruno J ^b   Hermes, Djuli M ^a   Ribeiro, Vanessa B ^c   Zavascki, Alexandre P ^d  

^a University of Health Sciences of Porto Alegre   (Brazil)

^b Centro Universitario Metodista IPA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; IMIPENEM; MEROPENEM; POLYMYXIN B; PROTEIN OXA 23; RIFAMPICIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; COMBINATION CHEMOTHERAPY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B;

EID: 84880963158     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.02.002     Document Type: Letter

References (5)

1. Martins A.F., Kuchenbecker R.S., Pilger K.O., et al. High endemic levels of multidrug-resistant Acinetobacter baumannii among hospitals in southern Brazil. Am J Infect Control 2012, 40:108-112.
2. Bergen P.J., Landersdorfer C.B., Zhang J., et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?. Diagn Microbiol Infect Dis 2012, 74:213-223.
3. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 20th ed.: approved standard M07-A8 2011, CLSI, Wayne, PA.
4. Lim T.-P., Tan T.-Y., Lee W., et al. In-vitro activity of polymyxin b, rifampicin, tigecycline alone and in combination against carbapenem-resistant acinetobacter baumannii in Singapore. PLoS ONE 2011, 6:18485.
5. Yilmaz E.M., Sunbula M., Aksoyb A., Yilmaza H., Guneyc A.K., Guvencd T. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 2012, 40:332-336.